Payment overview · 2025
General Payments
$15.96
1 reported records · 1 companies
Healthcare provider profile · identity verified
Grigoriy Krichmar, D.O.
Allopathic & Osteopathic Physicians|Internal Medicine · MASSAPEQUA, NY · NPI 1043371164
Verified facts
What the public records show
CMS Open Payments records show Grigoriy Krichmar, D.O. received $15.96 in general payments during 2025 across 1 reported records.
Otsuka Pharmaceutical Development & Commercialization, Inc. accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Otsuka Pharmaceutical Development & Commercialization, Inc. | Unresolved — no canonical attribution shown | $15.96 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $15.96 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| REXULTI Normalized: rexulti |
Drug | Otsuka Pharmaceutical Development & Commercialization, Inc. | $15.96 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Levothyroxine Sodium | Levothyroxine Sodium | 679 | 68 |
| Atorvastatin Calcium | Atorvastatin Calcium | 651 | 93 |
| Pantoprazole Sodium | Pantoprazole Sodium | 594 | 89 |
| Eliquis | Apixaban | 566 | 63 |
| Famotidine | Famotidine | 466 | 43 |
| Furosemide | Furosemide | 463 | 69 |
| Amlodipine Besylate | Amlodipine Besylate | 454 | 63 |
| Escitalopram Oxalate | Escitalopram Oxalate | 442 | 49 |
| Gabapentin | Gabapentin | 440 | 51 |
| Mirtazapine | Mirtazapine | 367 | 27 |
| Tamsulosin Hcl | Tamsulosin Hcl | 351 | 38 |
| Metoprolol Succinate | Metoprolol Succinate | 343 | 56 |
| Losartan Potassium | Losartan Potassium | 335 | 41 |
| Sertraline Hcl | Sertraline Hcl | 312 | 25 |
| Potassium Chloride | Potassium Chloride | 307 | 50 |
| Baclofen | Baclofen | 284 | 14 |
| Metoprolol Tartrate | Metoprolol Tartrate | 222 | 36 |
| Torsemide | Torsemide | 222 | 23 |
| Omeprazole | Omeprazole | 205 | 24 |
| Midodrine Hcl | Midodrine Hcl | 201 | 14 |
| Clopidogrel | Clopidogrel Bisulfate | 196 | 21 |
| Carvedilol | Carvedilol | 183 | 22 |
| Lisinopril | Lisinopril | 172 | 17 |
| Doxazosin Mesylate | Doxazosin Mesylate | 170 | 14 |
| Levetiracetam | Levetiracetam | 169 | 27 |
| Memantine Hcl Er | Memantine Hcl | 168 | suppressed |
| Finasteride | Finasteride | 154 | 20 |
| Donepezil Hcl | Donepezil Hcl | 150 | 22 |
| Hydralazine Hcl | Hydralazine Hcl | 150 | 24 |
| Labetalol Hcl | Labetalol Hcl | 145 | 11 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 144 | 30 |
| Simvastatin | Simvastatin | 127 | 23 |
| Divalproex Sodium | Divalproex Sodium | 125 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 117 | suppressed |
| Xarelto | Rivaroxaban | 115 | 13 |
| Prednisone | Prednisone | 113 | 20 |
| Sucralfate | Sucralfate | 109 | 14 |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 105 | 31 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 101 | 14 |
| Ezetimibe | Ezetimibe | 100 | 11 |
| Methenamine Hippurate | Methenamine Hippurate | 100 | suppressed |
| Allopurinol | Allopurinol | 97 | suppressed |
| Santyl | Collagenase Clostridium Hist. | 95 | 19 |
| Metformin Hcl | Metformin Hcl | 91 | 14 |
| Aripiprazole | Aripiprazole | 89 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 88 | suppressed |
| Duloxetine Hcl | Duloxetine Hcl | 79 | suppressed |
| Scopolamine | Scopolamine | 78 | 24 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 74 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 73 | suppressed |
| Alprazolam | Alprazolam | 67 | 17 |
| Entresto | Sacubitril/Valsartan | 67 | suppressed |
| Letrozole | Letrozole | 67 | suppressed |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 64 | 20 |
| Montelukast Sodium | Montelukast Sodium | 62 | 13 |
| Atenolol | Atenolol | 59 | suppressed |
| Olanzapine | Olanzapine | 59 | suppressed |
| Budesonide | Budesonide | 55 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 55 | suppressed |
| Memantine Hcl | Memantine Hcl | 54 | 12 |
| Riluzole | Riluzole | 54 | suppressed |
| Hydrochlorothiazide | Hydrochlorothiazide | 51 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 51 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 50 | suppressed |
| Brilinta | Ticagrelor | 48 | suppressed |
| Bupropion Xl | Bupropion Hcl | 48 | suppressed |
| Enulose | Lactulose | 47 | suppressed |
| Trazodone Hcl | Trazodone Hcl | 46 | 13 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 45 | 18 |
| Enalapril Maleate | Enalapril Maleate | 45 | suppressed |
| Nuedexta | Dextromethorphan Hbr/Quinidine | 45 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 44 | suppressed |
| Nateglinide | Nateglinide | 44 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 43 | suppressed |
| Movantik | Naloxegol Oxalate | 43 | suppressed |
| Risperidone | Risperidone | 43 | suppressed |
| Valsartan | Valsartan | 43 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 41 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 40 | 11 |
| Buspirone Hcl | Buspirone Hcl | 39 | suppressed |
| Valproic Acid | Valproic Acid (As Sodium Salt) | 38 | suppressed |
| Dilantin | Phenytoin | 37 | suppressed |
| Bumetanide | Bumetanide | 36 | suppressed |
| Fiasp Flextouch | Insulin Aspart (Niacinamide) | 36 | suppressed |
| Cinacalcet Hcl | Cinacalcet Hcl | 35 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 35 | 15 |
| Spironolactone | Spironolactone | 34 | suppressed |
| Epogen | Epoetin Alfa | 33 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 33 | suppressed |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 32 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 32 | suppressed |
| Procrit | Epoetin Alfa | 32 | suppressed |
| Latanoprost | Latanoprost | 30 | suppressed |
| Novolog Flexpen | Insulin Aspart | 30 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 30 | suppressed |
| Retacrit | Epoetin Alfa-Epbx | 30 | suppressed |
| Brimonidine Tartrate | Brimonidine Tartrate | 29 | suppressed |
| Carbamazepine | Carbamazepine | 29 | suppressed |
| Linzess | Linaclotide | 29 | suppressed |
| Sodium Chloride | 0.9 % Sodium Chloride | 29 | suppressed |
| Dapagliflozin | Dapagliflozin Propanediol | 28 | suppressed |
| Digoxin | Digoxin | 28 | suppressed |
| Novofine Autocover | Pen Needle, Diabetic, Safety | 28 | 13 |
| Pioglitazone Hcl | Pioglitazone Hcl | 27 | suppressed |
| Atrovent Hfa | Ipratropium Bromide | 26 | suppressed |
| Myrbetriq | Mirabegron | 26 | suppressed |
| Nifedipine Er | Nifedipine | 25 | suppressed |
| Atomoxetine Hcl | Atomoxetine Hcl | 24 | suppressed |
| Budesonide Dr | Budesonide | 24 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 24 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 24 | suppressed |
| Glimepiride | Glimepiride | 24 | suppressed |
| Silodosin | Silodosin | 24 | suppressed |
| Nystatin | Nystatin | 23 | 16 |
| Enoxaparin Sodium | Enoxaparin Sodium | 22 | suppressed |
| Gemtesa | Vibegron | 22 | suppressed |
| Irbesartan | Irbesartan | 22 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 21 | suppressed |
| Ozempic | Semaglutide | 21 | suppressed |
| Silver Sulfadiazine | Silver Sulfadiazine | 21 | suppressed |
| Albuterol Sulfate | Albuterol Sulfate | 20 | suppressed |
| Gemfibrozil | Gemfibrozil | 20 | suppressed |
| Jantoven | Warfarin Sodium | 20 | suppressed |
| Rivastigmine | Rivastigmine | 20 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 19 | suppressed |
| Anastrozole | Anastrozole | 19 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 18 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 18 | suppressed |
| Xifaxan | Rifaximin | 18 | suppressed |
| Abrysvo | Rsv Vacc, Pref A And Pref B/Pf | 17 | 17 |
| Methimazole | Methimazole | 17 | suppressed |
| Daptomycin | Daptomycin | 16 | suppressed |
| Insulin Aspart Flexpen | Insulin Aspart | 16 | suppressed |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 16 | suppressed |
| Lacosamide | Lacosamide | 16 | suppressed |
| Glipizide | Glipizide | 15 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 15 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 15 | suppressed |
| Lamotrigine | Lamotrigine | 15 | suppressed |
| Lokelma | Sodium Zirconium Cyclosilicate | 15 | suppressed |
| Mupirocin | Mupirocin | 15 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 14 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 14 | suppressed |
| Erythromycin | Erythromycin Base | 14 | suppressed |
| Fluticasone Propionate Hfa | Fluticasone Propionate | 14 | suppressed |
| Lumigan | Bimatoprost | 14 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 14 | suppressed |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 13 | suppressed |
| Darifenacin Er | Darifenacin Hydrobromide | 13 | suppressed |
| Heparin Sodium | Heparin Sodium,porcine | 13 | suppressed |
| Janumet Xr | Sitagliptin Phos/Metformin Hcl | 13 | suppressed |
| Methazolamide | Methazolamide | 13 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 13 | suppressed |
| Raloxifene Hcl | Raloxifene Hcl | 13 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 13 | suppressed |
| Tiotropium Bromide | Tiotropium Bromide | 13 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 13 | suppressed |
| Ceftriaxone | Ceftriaxone Sodium | 12 | suppressed |
| Dutasteride | Dutasteride | 12 | suppressed |
| Jardiance | Empagliflozin | 12 | suppressed |
| Lorazepam | Lorazepam | 12 | suppressed |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 12 | suppressed |
| Timolol Maleate | Timolol Maleate/Pf | 12 | suppressed |
| Tramadol Hcl | Tramadol Hcl | 12 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 11 | suppressed |
| Carteolol Hcl | Carteolol Hcl | 11 | suppressed |
| Dorzolamide Hcl | Dorzolamide Hcl | 11 | suppressed |
| Glatopa | Glatiramer Acetate | 11 | suppressed |
| Novofine 32 | Pen Needle, Diabetic | 11 | suppressed |
| Nystop | Nystatin | 11 | suppressed |
| Oxcarbazepine | Oxcarbazepine | 11 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $15.96 · 1 records | Otsuka Pharmaceutical Development & Commercialization, Inc. | REXULTI | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error